Bone Marrow Transplant Support Foundation
About Bone Marrow Transplant Support Foundation
Data last updated: 10 March 2026
Bone Marrow Transplant Support Foundation is a private not for profit company based in Pune, Maharashtra, India. It specialises in healthcare services, a part of the broader healthcare sector. Incorporated on 17 March 2020, the company has been in operation for over 6 years.
Registered with ROC Pune under CIN U85100PN2020NPL190395.
Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Neerad Jishnukumar Trivedi and Sheetal Divakar Vaidya.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: C/O Shri Neerad J Trivedi Fl – 502 Olive Court Parmar Park Ph – I Sn.77/48 Wanawadi, Pune, Maharashtra, India – 411040.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.62 Lakh, a decline of 79% compared to the previous year.
-
Email*****@*****.com
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressC/O Shri Neerad J Trivedi Fl – 502 Olive Court Parmar Park Ph – I Sn.77/48 Wanawadi, Pune, Maharashtra, India – 411040
-
IndustryHealthcare, Human Health Activities
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Business Activity of Bone Marrow Transplant Support Foundation
Bone Marrow Transplant Support Foundation is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | ********* |
Board of Directors of Bone Marrow Transplant Support Foundation
Bone Marrow Transplant Support Foundation is governed by 2 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neerad Jishnukumar Trivedi | Director | 17 Mar 2020 | 6 Years 3 Months | Current |
|
Sheetal Divakar Vaidya
Also directs:
Aashwast Services Llp
|
Director | 17 Mar 2020 | 6 Years 3 Months | Current |
Financials of Bone Marrow Transplant Support Foundation FY 2025 filings available
Bone Marrow Transplant Support Foundation reported revenue of ₹1.62 Lakh (down 79% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
View Bone Marrow Transplant Support Foundation's control and ownership data: shareholding patterns, funding details, FII information, directors and KMP remuneration, group structure, overseas investment and related data.
-
Promoters: **.**%
-
Public: **.**%
-
Others: **.**%
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | |
|---|---|---|---|---|---|
| Promoters | **.** | **.** | **.** | **.** | **.** |
| Public | **.** | **.** | **.** | **.** | **.** |
| Others | **.** | **.** | **.** | **.** | **.** |
Full shareholding pattern with quarterly trends.
Charges & Borrowings Bone Marrow Transplant Support Foundation
Bone Marrow Transplant Support Foundation does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bone Marrow Transplant Support Foundation
View historical data on people associated with Bone Marrow Transplant Support Foundation, including employment history and EPFO contributions.
Employee Count & EPFO Data of Bone Marrow Transplant Support Foundation
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Bone Marrow Transplant Support Foundation
GSTIN & GST Filing Data of Bone Marrow Transplant Support Foundation
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Bone Marrow Transplant Support Foundation
Credit Ratings, Legal Cases & Regulatory Alerts of Bone Marrow Transplant Support Foundation
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Bone Marrow Transplant Support Foundation
MSME Payment Delays by Bone Marrow Transplant Support Foundation
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Bone Marrow Transplant Support Foundation
Subsidiaries & Group Companies of Bone Marrow Transplant Support Foundation
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Bone Marrow Transplant Support Foundation with ownership details.
MCA Filings & Documents of Bone Marrow Transplant Support Foundation
MCA Filings & Documents of Bone Marrow Transplant Support Foundation
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Bone Marrow Transplant Support Foundation
Frequently Asked Questions about Bone Marrow Transplant Support Foundation
Bone Marrow Transplant Support Foundation is an active private not for profit company in the healthcare sector based in Pune, Maharashtra, India. It was incorporated on 17 March 2020 (6+ years old) and is registered under CIN U85100PN2020NPL190395.
Bone Marrow Transplant Support Foundation reported revenue of ₹1.62 Lakh for FY 2025 (down 79.00% YoY).
The current directors of Bone Marrow Transplant Support Foundation are:
The primary industry of Bone Marrow Transplant Support Foundation is healthcare. The company specifically operates in human health activities. The company is currently active in this sector.
Bone Marrow Transplant Support Foundation can be reached at the registered office: CO Shri Neerad J Trivedi Fl – 502 Olive Court Parmar Park Ph – I Sn.7748 Wanawadi, Pune, Maharashtra, India – 411040.
The authorised capital is ₹10 Lakh, and the paid-up capital is ₹10 Lakh.